TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.

Also called NCT02505399

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 180 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02505399
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02505399. Randomized; double masking; primary purpose prevention. Start 2015-11 (registry gives no type); primary completion 2018-05-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
Acronym
TIRATROP
Condition
Atherosclerosis
Intervention (Drug)
ticagrelor
Intervention (Drug)
clopidogrel
Lead sponsor
University Hospital, Toulouse (class: other)

Record details

Record id
cardio:ct-nct02505399
Content hash
392b4ba6c93ddf242790c5f8ff778f4944b6e40f2c9c9f20a84bc6a4eff966df